When the ob/ob mutation is placed on a BTBR background, the mice are initially insulin resistant with elevated insulin levels, pancreatic islet hypertrophy, and marked hyperglycemia by 6 weeks of age [46]. This evidence concerns the gene INS and Hyperglycemia.